Combined Manual Therapy and Percutaneous Neuromodulation for Moderate Carpal Tunnel Syndrome

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-50
SponsorUniversidad Europea de Valencia

About this trial

Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy and can cause pain, numbness, tingling, and functional impairment of the hand. Although surgical decompression is considered an effective treatment for moderate CTS, there is increasing interest in conservative therapeutic strategies that may improve symptoms and function while avoiding surgery.

The aim of this multicenter non-randomized controlled trial is to evaluate the effectiveness of a combined intervention consisting of manual therapy and ultrasound-guided percutaneous neuromodulation compared with conventional postsurgical rehabilitation in patients with moderate CTS.

Participants allocated to the experimental group will receive a standardized multimodal physiotherapy program including manual therapy techniques and ultrasound-guided percutaneous neuromodulation, whereas participants in the control group will undergo standard rehabilitation following carpal tunnel release surgery. The primary outcome will be symptom severity and functional status assessed with the Boston Carpal Tunnel Questionnaire. Secondary outcomes will include pain intensity, nerve conduction parameters, ultrasound measures, hand strength, patient-reported outcomes, and adverse events.

The findings of this study are expected to provide evidence regarding the potential role of combined conservative treatment as an alternative therapeutic strategy for patients with moderate carpal tunnel syndrome.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 30 to 50 years.

Clinical diagnosis of moderate carpal tunnel syndrome confirmed by nerve conduction studies according to the American Association of Electrodiagnostic Medicine criteria.

Symptoms persisting for at least 3 months.

Ability to understand the study procedures and provide written informed consent.

Disqualifiers

Previous surgery for carpal tunnel syndrome in the affected hand (experimental group only).

Severe carpal tunnel syndrome requiring urgent surgical intervention.

History of wrist fracture or major upper-limb trauma affecting the study limb.

Pregnancy.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Combined Manual Therapy and Ultrasound-Guided Percutaneous Neuromodulation

    Procedure/Surgery

    Participants will receive a multimodal conservative treatment consisting of manual therapy and ultrasound-guided percutaneous neuromodulation. Manual therapy will include myofascial release, passive accessory joint mobilization, cervical mobilization when indicated, and median nerve neurodynamic mobilization. Ultrasound-guided percutaneous neuromodulation will be applied to the median nerve using low-frequency electrical stimulation according to a standardized protocol.

  • Postsurgical Rehabilitation

    Other intervention

    Participants will receive a standardized physiotherapy program following carpal tunnel release surgery, including transcutaneous electrical nerve stimulation (TENS), active and passive mobilization exercises, strengthening exercises, stretching, cryotherapy, and soft tissue techniques as clinically indicated.

Treatment groups

150 Participants
are divided into 2 treatment groups
Group A: Combined Manual Therapy and Percutaneous NeuromodulationExperimental treatment 1 intervention
Group B: Postsurgical Rehabilitation.Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Boston Carpal Tunnel Questionnaire (BCTQ) total score

The primary outcome is the change in symptom severity and functional status assessed using the Boston Carpal Tunnel Questionnaire (BCTQ), a validated patient-reported outcome measure for carpal tunnel syndrome.

Time frame
Baseline and 6 weeks

Secondary outcomes

1

Pain intensity

Pain intensity assessed using the Visual Analogue Scale (VAS).

Time frame
Baseline and 6 weeks

Other outcomes

1

Upper-limb disability

Upper-limb disability assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire.

Time frame
Baseline, 3 weeks, 6 weeks, and 4-week follow-up
2

Median nerve sensory conduction velocity

Sensory conduction velocity (m/s) assessed by standardized nerve conduction studies.

Time frame
Baseline, 3 weeks, 6 weeks, and 4-week follow-up
3

Median nerve distal motor latency

Distal motor latency (ms) assessed by standardized nerve conduction studies.

Time frame
Baseline, 3 weeks, 6 weeks, and 4-week follow-up

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: